BR9812321A - Modulation of immune responses - Google Patents

Modulation of immune responses

Info

Publication number
BR9812321A
BR9812321A BR9812321-1A BR9812321A BR9812321A BR 9812321 A BR9812321 A BR 9812321A BR 9812321 A BR9812321 A BR 9812321A BR 9812321 A BR9812321 A BR 9812321A
Authority
BR
Brazil
Prior art keywords
group
immune
modulation
alkenyl
animal
Prior art date
Application number
BR9812321-1A
Other languages
Portuguese (pt)
Inventor
Carl John Landauer
Gabriel Johannes Du Preez
Voker Reinhard Schillack
Derrick Cecil Attfield
Johannes Beyers Den Bogaerde
Original Assignee
Frangold Holdings Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frangold Holdings Limited filed Critical Frangold Holdings Limited
Publication of BR9812321A publication Critical patent/BR9812321A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: <B>"MODULAçãO DE RESPOSTAS IMUNOLóGICAS"<D>. Um processo de afetar ou de modular para estímulo ou supressão do produto da célula imunológica de acordo com uma resposta inunológica a um estimulante imunológico externo ou endógeno em um animal que compreende as etapas de administração a tal animal de uma quantidade eficaz moduladora imune não-tóxica de um composto selecionado do grupo que consiste em compostos de fórmula geral (I) R~ 1~-CO-NR~ 2~R~ 3~ em que R~ 1~ é selecionado do grupo que consiste em H e grupos alquila inferior (isto é, C~ 1~ a C~ 3~) e C~ 2~ a C~ 3~ alquenila; R~ 2~ e R~ 3~ são os mesmos ou diferentes e cada um é selecionado do grupo que consiste em H, grupos alquila inferior (isto é, C~ 1~ a C~ 3~) e C~ 2~ a C~ 3~ alquenila que podem opcionalmente ser halogenados ou hidroxilados ou que podem em combinação um com o outro formar um grupo -(CH~ 2~)<B>~ n~<D>- em que n é qualquer número de 2 a 5 ou o grupo -(CH~ 2~)~ 2~-O-(CH~ 2~)~ 2~ e metabólitos e pró-drogas dos mesmos. O processo é útil no tratamento de uma variedade de enfermidades associadas a respostas imunológicas inapropriadas e a invenção fornece o uso de compostos de Fórmula (I) na fabricação de medicamentos para uso no tratamento de tais enfermidades e para preparações farmacêuticas que contêm os mesmos.Invention Patent: <B> "MODULATION OF IMMUNOLOGICAL RESPONSES" <D>. A process of affecting or modulating to stimulate or suppress the immune cell product in accordance with an inunological response to an external or endogenous immune stimulant in an animal comprising the steps of administering to such an animal a non-toxic immune modulating effective amount of a compound selected from the group consisting of compounds of the general formula (I) R ~ 1 ~ -CO-NR ~ 2 ~ R ~ 3 ~ where R ~ 1 ~ is selected from the group consisting of H and lower alkyl groups ( i.e., C ~ 1 ~ to C ~ 3 ~) and C ~ 2 ~ to C ~ 3 ~ alkenyl; R ~ 2 ~ and R ~ 3 ~ are the same or different and each is selected from the group consisting of H, lower alkyl groups (ie, C ~ 1 ~ to C ~ 3 ~) and C ~ 2 ~ to C ~ 3 ~ alkenyl which can optionally be halogenated or hydroxylated or which can in combination with one another form a group - (CH ~ 2 ~) <B> ~ n ~ <D> - where n is any number from 2 to 5 or the group - (CH ~ 2 ~) ~ 2 ~ -O- (CH ~ 2 ~) ~ 2 ~ and their metabolites and prodrugs. The process is useful in the treatment of a variety of diseases associated with inappropriate immune responses and the invention provides the use of compounds of Formula (I) in the manufacture of medicaments for use in the treatment of such diseases and for pharmaceutical preparations containing them.

BR9812321-1A 1997-09-16 1998-09-16 Modulation of immune responses BR9812321A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA978319 1997-09-16
PCT/US1998/019126 WO1999013885A1 (en) 1997-09-16 1998-09-16 Modulation of immune responses

Publications (1)

Publication Number Publication Date
BR9812321A true BR9812321A (en) 2000-09-05

Family

ID=25586589

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812321-1A BR9812321A (en) 1997-09-16 1998-09-16 Modulation of immune responses

Country Status (10)

Country Link
EP (1) EP1019063A4 (en)
JP (1) JP2001516721A (en)
CN (1) CN1279612A (en)
AU (1) AU737867B2 (en)
BR (1) BR9812321A (en)
CA (1) CA2304119A1 (en)
IL (1) IL135091A0 (en)
NO (1) NO20001341L (en)
NZ (1) NZ503418A (en)
WO (1) WO1999013885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324631A1 (en) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited A substance or composition for the treatment of cancer
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition

Also Published As

Publication number Publication date
AU737867B2 (en) 2001-09-06
JP2001516721A (en) 2001-10-02
CN1279612A (en) 2001-01-10
EP1019063A4 (en) 2003-09-03
NO20001341L (en) 2000-05-16
NZ503418A (en) 2001-02-23
AU9389098A (en) 1999-04-05
WO1999013885A1 (en) 1999-03-25
EP1019063A1 (en) 2000-07-19
CA2304119A1 (en) 1999-03-25
NO20001341D0 (en) 2000-03-15
IL135091A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
BR9908764A (en) Compound and its pharmaceutically acceptable salts or hydrolysable esters in vivo, use of these, process for preparing them, and pharmaceutical composition
BR9807339A (en) 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising them.
BR9913592A (en) Compounds, compound preparation process, and pharmaceutical compositions
NO170280C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULPHAMATE DERIVATIVES
KR960703598A (en) AGENT FOR CURING NEUROTIC DISEASES
BR0010716A (en) Phenyl compounds substituted with immunosuppressive activity and pharmaceutical compositions
FR2387954A1 (en) MERCAPTOALKYLSULFONYLPROLINE DERIVATIVES AND RELATED COMPOUNDS, AND THEIR USE AS MEDICINAL PRODUCTS
SE8902326L (en) CARBOXAMIDE COMPOUNDS, PROCEDURES FOR THE PREPARATION OF THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2432511A1 (en) TRIAZOLIC DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
PT87190A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR REDUCING THE INDESEJAVIC EFFECTS OF BETA-LACTAMINES
FI865233A0 (en) PYRAZOLINDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING SOM MEDEL MED INSEKTICID OCH AKARICID VERKAN.
BR9007758A (en) PROCESS TO INHIBIT GROWTH OR REPLICATION OF HUMAN DEFICIENCY VIRUSES, COMPOUNDS, INTERMEDIATE COMPOUND AND PHARMACEUTICAL FORMULATION TO INHIBIT HIV GROWTH OR REPLICATION
ES2111556T3 (en) NEW ALKYL-HETEROCICLIC AMINES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
BR0012610A (en) New diphenylpiperidine derivative
ATE55695T1 (en) USE OF DEFIBROTIDE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES.
PT81855B (en) PREPARATION PROCESS OF ARILCYCLOBUTILALQUILAMINS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2391215A1 (en) NEW IMIDAZOAZINES AND IMIDAZODIAZINES, THEIR PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS
SE8801514D0 (en) PHARMACEUTICAL COMPOSITION
EA199900135A1 (en) DERIVATIVES OF PYRAZOLOPIRIDINE AND THEIR APPLICATION AS A PHARMACEUTICAL PREPARATION
HUP9801881A2 (en) Hydroximic acid derivatives, preparation and use thereof, pesticide and fungicide compositions containing these compounds as active ingredients
GR3017234T3 (en) Foamable washing composition based on selected insoluble silicones and an alkylpolyglycoside, and cosmetic and dermatological uses thereof.
EP0271013A3 (en) Basic substituted phenyl acetonitriles, their preparation and medicaments containing them
BR9903282A (en) Nitrone compounds, a process for preparing them and pharmaceutical compositions containing the same
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
PT95854A (en) PROCESS FOR THE PREPARATION OF COMPOSITIONS CONTAINING PYRIMIDONE DERIVATIVES AND ANALOGS, USEFUL IN THE TREATMENT OF ASTHMA AND CERTAIN SKIN PERTURBACTIONS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.